NF-κB p65/p52 plays a role in GDNF up-regulating Bcl-2 and Bcl-w expression in 6-OHDA-induced apoptosis of MN9D cell

International Journal of Neuroscience

Volumn 123, Issue 10, 2013, Pages 705-710

  Cao, Jun Ping ^a   Niu, Hong Yan ^a   Wang, Hong Jun ^a   Huang, Xian Gui ^a   Gao, Dian Shuai ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

6 hydroxydopamine; Bad; Bax; Bcl 2; Bcl w; Glial cell line derived neurotrophic factor; MN9D cell; Nuclear factor (NF) B (p65 p52)

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; I KAPPA B; NEUROTOXIN; OXIDOPAMINE; PLASMID DNA; PROTEIN BAD; PROTEIN BCL 2; PROTEIN BCL W; PROTEIN P100; PROTEIN P52; SHORT HAIRPIN RNA; SIP100 PROTEIN; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL STRAIN MN9D; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; EMBRYO DEVELOPMENT; MESENCEPHALON; MOUSE; NERVE CELL; NEUROPROTECTION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-ASSOCIATED DEATH PROTEIN; BLOTTING, WESTERN; DOPAMINERGIC NEURONS; GENES, BCL-2; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HYDROXYDOPAMINES; MESENCEPHALON; MICE; NF-KAPPA B P52 SUBUNIT; PLASMIDS; PROTEINS; RNA, SMALL INTERFERING; TRANSCRIPTION FACTOR RELA; TRANSFECTION;

EID: 84884394301     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2013.795149     Document Type: Article

References (30)

1. Lin LF, Doherty DH, Lile JD, et al. GDNF: a glial cell linederived neurotrophic factor for midbrain dopaminergic neurons. Science 1993;260:1130-2. (Pubitemid 23186789)
2. Kobayashi H, Fukuhara K, Tada-Oikawa S, et al. The mechanisms of oxidative DNA damage and apoptosis induced by norsalsolinol, an endogenous tetrahydroisoquinoline derivative associated with Parkinson's disease. J Neurochem 2009;108(2):397-407.
3. Chipuk JE, Fisher JC, Dillon CP, et al.Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins. PNAS 2008;105:20327-32.
4. Paradis E, Douillard HE, Koutroumanis M, et al. Amyloid β peptide of Alzheimer's disease downregulates Bcl-2 and upregulates Bax expression in human neurons. J Neurosci 1996;16:7533-9. (Pubitemid 26389692)
5. Cheng B, Yang X,Hou Z, et al.D-beta-hydroxybutyrate inhibits the apoptosis of PC12 cells induced by 6-OHDA in relation to up-regulating the ratio of Bcl-2/Bax mRNA. Auton Neurosci 2007;134(1-2):38-44. (Pubitemid 46900909)
6. Kramer BC, Mytilineou C. Alterations in the cellular distribution of bcl-2, bcl-x and bax in the adult rat substantia nigra following striatal 6-hydroxydopamine lesions. J Neurocytol 2004;33(2):213-23. (Pubitemid 38885738)
7. Karin M, Yamamoto Y, Wang QM. The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov 2004;3:17-26. (Pubitemid 38088695)
8. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998;16:225-60. (Pubitemid 28183365)
9. Lich JD, Williams KL, Moore CB, et al. Cutting edge: monarch-1 suppresses non-canonical NF-κB activation and p52-dependent chemokine expression in monocytes. J Immunol 2007;178:1256-60. (Pubitemid 46154594)
10. Cao JP, Wang HJ, Yu JK, et al. The involvement of NF-kappaB p65/p52 in the effects of GDNF on DA neurons in early PD rats. Brain Res Bull 2008;76(5):505-11.
11. Sun Y, Huang XG, Liu MY, et al. A new alternative NF-κB Pathway mediated the neuroprotection of GDNF on 6-OHDA-induced DA neurons neurotoxicity. Brain Res 2012;1437:38-49.
12. Choi HK, Won LA, Kontur PJ, et al. Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion. Brain Res 1991;552(1):67-76.
13. Choi HK, Won LA, Roback JD, et al. Specific modulation of dopamine expression in neuronal hybrid cells by primary cells from different brain regions. PNAS 1992;89: 8943-7.
14. Rolland AS,Herrero MT, VirginiaGM, et al. Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism. Brain 2007;130:265-75.
15. Gorman AM, Szegezdi E, Quigney DJ, et al. Hsp27 inhibits 6-hydroxydopamine-induced cytochrome c release and apoptosis in PC12 cells. Biochem Biophys Res Commun 2005;327(3):801-10. (Pubitemid 40092820)
16. Hu XM, Weng ZF, Chu CT, et al. Peroxiredoxin-2 protects against 6-hydroxydopamine-induced dopaminergic neurodegeneration via attenuation of the apoptosis signal-regulating kinase (ASK1) signaling cascade. J Neurosci 2011;31:247-61.
17. Ugarte SD, Lin E, Klann E, et al. Effects of GDNF on 6-OHDA-induced death in a dopaminergic cell line: modulation by inhibitors of PI3 kinase and MEK. J Neurosci Res 2003;73(1):105-12. (Pubitemid 36791375)
18. Holmgreen SP, Huang DC, Adams JM, et al. Survival activity of Bcl-2 homologs Bcl-w and A1 only partially correlates with their ability to bind pro-apoptotic family members. Cell Death Differ 1999;6(6):525-32. (Pubitemid 29292108)
19. Lang-Rollin I, Maniati M, Jabado O, et al. Apoptosis and the conformational change of Bax induced by proteasomal inhibition of PC12 cells are inhibited by bcl-xL and bcl-2. Apoptosis 2005;10(4):809-20. (Pubitemid 41187079)
20. Manakova S, Puttonen KA, Raasmaja A, et al. The roles of dopamine transporter and Bcl-2 protein in the protection of CV1-P cells from 6-OHDA-induced toxicity. Toxicol Lett 2004;154:117-23. (Pubitemid 39314595)
21. Natsume A, Mata M, Goss J, et al. Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration. Exp Neurol 2001;169(2):231-8. (Pubitemid 32524419)
22. EbadiM, Sharma SK,Wanpen S, et al. Coenzyme Q10 inhibits mitochondrial complex-1 down-regulation and nuclear factorkappa B activation. J Cell Mol Med 2004;8:213-22. (Pubitemid 44145510)
23. Ghosh A, Roy A, Liu XJ, et al. Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease. PNAS 2007;104:18754-9. (Pubitemid 350210769)
24. SaldanaM, BonastreM, Aguilar E, et al. Role of nigral NFkappaB p50 and p65 subunit expression in haloperidol-induced neurotoxicity and stereotyped behavior in rats. Eur Neuropsychopharmacol 2006;16(7):491-497. (Pubitemid 44311001)
25. Lee HH, Dadgostar H, Cheng QW, et al. NF-κB-mediated upregulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. PNAS 1996; 96:9136-41. (Pubitemid 29374720)
26. Liu S, Shen H, Xu M, et al. FRP inhibits ox-LDL-induced endothelial cell apoptosis through an Akt-NF-κB-Bcl-2 pathway and inhibits endothelial cell apoptosis in an apoEknockout mouse model. Am J Physiol Endocrinol Metab 2010;299:E351-63.
27. Matsushita H, Morishita R, Nata T, et al. Hypoxia-induced endothelial apoptosis through nuclear factor-κB (NF-κB)-mediated bcl-2 suppression in vivo evidence of the importance of NF-κB in endothelial cell regulation. Circ Res 2000;86:974-81. (Pubitemid 30324310)
28. Zong WX, Edelstein LC, Chen C, et al. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis. Genes & Dev 1999;13:382-7. (Pubitemid 29108753)
29. Senftleben U, Cao YX, Xiao GT, et al. Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway, Science 2001;293:1495-9. (Pubitemid 32801552)
30. Xiao GT, Fong A, Sun SC. Induction of p100 processing by NF-κB-inducing kinase involves docking IκB kinaseα (IKKα) to p100 and IKKα-mediated phosphorylation. J Biol Chem 2004;279:30099-105. (Pubitemid 38937932)